60|10000|Public
5000|$|December 7, 1999 Laus; Reiner, Ruegg; Curtis Landon, Wu; HongyuImmunostimulatory compositions. Disclosed are {{therapeutic}} compositions {{and methods}} for inducing cytotoxic T cell responses in vitro and in vivo. The therapeutic compositions consist of antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen. <b>Also</b> <b>disclosed</b> <b>are</b> expression vectors and systems for producing the polypeptide complexes.|$|E
40|$|Carbon fiber {{reinforced}} {{carbon composite}} rotary sleeve, and disc valves for internal combustion engines {{and the like}} are disclosed. The valves are formed from knitted or braided or wrap-locked carbon fiber shapes. <b>Also</b> <b>disclosed</b> <b>are</b> valves fabricated from woven carbon fibers and from molded carbon matrix material. The valves of the present invention with their very low {{coefficient of thermal expansion}} and excellent thermal and self-lubrication properties do not present the sealing and lubrication problems that have prevented rotary sleeve and disc valves from operating efficiently and reliably in the past. <b>Also</b> <b>disclosed</b> <b>are</b> a sealing tang to further improve sealing capabilities and anti-oxidation treatments...|$|E
40|$|Cell-based and {{cell-free}} assays {{are disclosed}} that detect compounds that promote aggregation of proteins, glycoproteins, and protein-nucleic acid complexes. <b>Also</b> <b>disclosed</b> <b>are</b> pharmaceutical formulations useful for treating or preventing viral infections, bacterial infections, cancer, and diseases involving hyper-proliferative cells. published_or_final_versio...|$|E
40|$|A {{process for}} the {{preparation}} of a substituted guanidine by reacting a substituted cyanamide with ammonia or a substituted amine {{in the presence of}} a Lewis acid catalyst. <b>Also</b> <b>disclosed</b> <b>is</b> a {{process for the}} preparation of a tri-substituted guanidine by reacting a mono-substituted cyanamide with a di-substituted amine...|$|R
40|$|The present {{invention}} {{relates to}} a novel {{process for the}} preparation of highly potent histamine receptor antagonists, in particular histamine H 3 receptor antagonists. <b>Also</b> <b>disclosed</b> <b>is</b> a novel process for the preparation of intermediates useful {{in the preparation of}} histamine receptor antagonists, in particular H 3 -receptor antagonists...|$|R
40|$|<b>Disclosed</b> <b>is</b> a thermally-stable SnO 2 -surfaced {{polyimide}} film {{wherein the}} electrical conductivity of the SnO 2 surface {{is within the}} range of about 3. 0 x 10 (exp - 3) to about 1 x 10 (exp - 2) ohms(exp - 1). <b>Also</b> <b>disclosed</b> <b>is</b> a method of preparing this film from a solution containing a polyamic acid and SnCl 4 (DMSO) 2...|$|R
40|$|Cell based and {{cell-free}} assays {{for identifying}} compounds that promote aggregation of proteins, glycoproteins, and protein-nucleic acid complexes are disclosed. <b>Also</b> <b>disclosed</b> <b>are</b> compounds, formulations and {{methods for treating}} or preventing viral infection, bacterial infection, cancer, or diseases involving hyper-proliferative cells. published_or_final_versio...|$|E
40|$|Disclosed are {{compounds}} comprising a benzenediol derivative {{bound to}} one or more fatty acids. <b>Also</b> <b>disclosed</b> <b>are</b> nutritional supplements, pharmaceutical formulations, delivery devices, and foodstuffs comprising the disclosed compounds. Methods of using the disclosed compounds and compositions to improve health are also disclosed...|$|E
40|$|Disclosed herein are nanoactuating rotaxanes {{comprising}} a threading component, the threading component comprising a oligoviologen, and {{at least}} two macrocylic components, wherein the oligoviologen is threaded through each of the macrocylic components. <b>Also</b> <b>disclosed</b> <b>are</b> methods for making and using the rotaxanes...|$|E
40|$|Firewall {{sandwich}} configurations having improved {{levels of}} system availability {{as well as}} an application-space implementation of a firewall load balancer (FLB) which provides greater operational flexibility while reducing the need for custom hardware and/or operating system software. <b>Also</b> <b>disclosed</b> <b>is</b> a firewall capable of functionally replacing an FLB upon detecting a failure therein...|$|R
40|$|<b>Disclosed</b> herein <b>is</b> a novel {{antifungal}} compound, derivatives {{that are}} used b treat fungal infections. In a specific embodiment, the compound is a small molecule. In a specific embodiment, the compound described herein inhibits yeast to hypha transition under robust hyphal inducing conditions at lower concentration of the molecule. <b>Also</b> <b>disclosed</b> <b>is</b> a composition comprising the antifungal compound. In a specific embodiment, the composition is a pharmaceutical composition <b>Also</b> <b>disclosed</b> <b>is</b> a method of treating and/or preventing fungal infection using the disclosed compound. The disclosed compound exhibits antifungal activity against wide range of fungal species at slightly higher concentrations. Antifungal compound <b>disclose</b> d herein <b>is</b> use d as anti-biofilm agent against fungal infections. In a specific embodiment, the <b>disclosed</b> compound <b>is</b> effective for systemic fungal infections. In a certain embodiment, the <b>disclosed</b> compound <b>is</b> a broad-spectrum antifungal agent for treating topical local and/or systemic fungal infections. In a specific embodiment, the <b>disclosed</b> compound <b>is</b> used in the prevention or treatment of mycotic infections caused by various fungal pathogens. published_or_final_versio...|$|R
40|$|<b>Disclosed</b> <b>is</b> a thermally-stable SnO. sub. 2 -surfaced {{polyimide}} film {{wherein the}} electrical conductivity of the SnO. sub. 2 surface {{is within the}} range of about 3. 0. times. 10. sup. - 3 to about 1. times. 10. sup. - 2 ohms. sup. - 1,. <b>Also</b> <b>disclosed</b> <b>is</b> a method of preparing this film from a solution containing a polyamic acid and SnCl. sub. 4 (DMSO). sub. 2...|$|R
40|$|Polymer-nanotube composites, fibers, and {{processes}} Disclosed are processes for preparing nanotube composite materials and fibers that provide exceptional nanotube alignment and dispersion. The disclosed processes include contacting nanotube dispersions with polymer melts. <b>Also</b> <b>disclosed</b> <b>are</b> nanotube composite fibers having high nanotube concentrations, exceptional nanotube alignment, and high thermal conductivity...|$|E
40|$|The present {{invention}} {{relates to}} dispersions of nanostructured carbon in organic solvents containing alkyl amide compounds and/or diamide compounds. The invention also relates to methods of dispersing nanostructured carbon in organic solvents {{and methods of}} mobilizing nanostructured carbon. <b>Also</b> <b>disclosed</b> <b>are</b> methods of determining the purity of nanostructured carbon...|$|E
40|$|A {{moldable}} material comprising {{a core of}} sized natural fibers (1), {{forming a}} continuous natural fiber strand sheathed in a sheath of thermoplastic (10), or optionally, may be chopped into pellets (14). <b>Also</b> <b>disclosed</b> <b>are</b> sized natural fiber products, natural fiber-containing products, and processes for making natural-fiber containing products and fiber-reinforced composite articles...|$|E
40|$|A {{machine for}} {{three-dimensional}} braiding of fibers {{is provided in}} which carrier members travel on a curved, segmented and movable braiding surface. The carrier members are capable of independent, self-propelled motion along the braiding surface. Carrier member position on the braiding surface is controlled and monitored by computer. <b>Also</b> <b>disclosed</b> <b>is</b> a yarn take-up device capable of maintaining tension in the braiding fiber...|$|R
40|$|A heat {{exchange}} of increased effectiveness <b>is</b> <b>disclosed.</b> A porous metal matrix is disposed {{in a metal}} chamber or between walls through which a heat-transfer fluid is directed. The porous metal matrix has internal bonds and is bonded to the chamber in order to remove all thermal contact resistance within the composite structure. Utilization of the invention in a rocket chamber <b>is</b> <b>disclosed</b> as a specific use. <b>Also</b> <b>disclosed</b> <b>is</b> a method of constructing the {{heat exchange}}r...|$|R
5000|$|August 19, 2008 Laus; Reiner, Ruegg; Curtis L., Shapero; Michael H., Yang; Demao Composition {{and method}} for {{producing}} an immune response against tumor-related antigens. <b>Disclosed</b> <b>are</b> a novel prostatic acid phosphatase and corresponding coding region derived from mouse. <b>Also</b> <b>disclosed</b> <b>is</b> {{a method of}} producing an immune response against an autologous polypeptide tumor antigen by immunizing a subject with a xenogeneic polypeptide antigen, either alone, {{as part of a}} viral antigen construct, or as part of a pulsed dendritic cell preparation.|$|R
40|$|A {{method of}} {{depositing}} a ceramic film, particularly a silicon carbide film, on a substrate is disclosed {{in which the}} residual stress, residual stress gradient, and resistivity are controlled. <b>Also</b> <b>disclosed</b> <b>are</b> substrates having a deposited film with these controlled properties and devices, particularly MEMS and NEMS devices, having substrates with films having these properties...|$|E
40|$|High {{throughput}} {{and virtual}} screening methods are disclosed that can identify potential anti-viral agents. The virtual screening methods identify agents that interact with a viral nucleoprotein binding site. The high throughput methods identify compounds that inhibit viral infection by binding to viral nucleoprotein. <b>Also</b> <b>disclosed</b> <b>are</b> pharmaceutical formulations useful for treating or preventing viral infections, especially influenza A. published_or_final_versio...|$|E
40|$|High Throughput And Virtual Screening Methods Are Disclosed That Can Identify Potential Anti-Viral Agents. The Virtual Screening Methods Identify Agents That Interact With A Viral Nucleoprotein Binding Site. The High Throughput Methods Identify Compounds That Inhibit Viral Infection By Binding To Viral Nucleoprotein. <b>Also</b> <b>Disclosed</b> <b>Are</b> Pharmaceutical Formulations Useful For Treating Or Preventing Viral Infections, Especially Influenza A. published_or_final_versio...|$|E
40|$|<b>Disclosed</b> herein <b>is</b> a novel rinsing agent, {{which may}} be {{suitable}} for use in surgical, and, in particular, ophthalmological procedures. The rinsing agent may by employed to remove emulsified oil droplets from the eye cavity. <b>Also</b> <b>disclosed</b> <b>is</b> a method for effectively removing emulsified silicone oil droplets remaining in the eye cavity after ophthalmological procedures using the disclosed rinsing agent {{in order to prevent}} the development of long-term complications associated with the emulsified oil droplets. published_or_final_versio...|$|R
40|$|This work {{focuses on}} {{centralized}} management of networked clients using Windows Server 2012 and its features. It involves creating an automated installation {{with a single}} configuration of the Windows operating system. It also includes implementation services and functions necessary for the smooth commissioning. The main part is devoted to software deployment through GPO policies and MSI installation packages. <b>Also</b> <b>disclosed</b> <b>is</b> the possibility of deployment using Windows PowerShell script...|$|R
40|$|An ink {{composition}} <b>is</b> <b>disclosed</b> {{which contains}} a novel type of dye (DYE) n(SAU) m that {{is capable of}} self-assembling under appropriate conditions, or is capable of assembling with another analogous dye (DYE') n'(SAU') m', or is capable of assembling with a compound (SAU'') p(X) q, thus forming supramolecular structures. <b>Also</b> <b>disclosed</b> <b>is</b> an ink jet printing process using these novel dyes, and an ink jet printing apparatus provided with an ink cartridge containing such a dye...|$|R
40|$|Ethynyl and {{substituted}} ethynyl-terminated polysulfones and {{a process}} for preparing the same are disclosed. These polysulfones are thermally cured to induce cross-linking and chain extension, producing a polymer system with improved solvent resistance and use temperature. <b>Also</b> <b>disclosed</b> <b>are</b> substituted 4 -ethynylbenzoyl chlorides as precursors to the substituted ethynyl-terminated polysulfones and {{a process for}} preparing the same...|$|E
40|$|Disclosed are emissive {{materials}} of formula (I) or (II), comprising two bidentate NO-type ligands, or a tetradentate NOON-type ligand, and a transition metal. The emissive materials are useful as electrophosphorescent emitters in organic light-emitting devices. <b>Also</b> <b>disclosed</b> <b>are</b> methods for preparing organic light-emitting diodes comprising these emissive materials, {{and the use}} of such diodes as white and yellow organic light-emitting devices. published_or_final_versio...|$|E
40|$|Disclosed Are Emissive Materials Of Formula (I) Or (Ii), Comprising Two Bidentate No-Type Ligands, Or A Tetradentate Noon-Type Ligand, And A Transition Metal. The Emissive Materials Are Useful As Electrophosphorescent Emitters In Organic Light-Emitting Devices. <b>Also</b> <b>Disclosed</b> <b>Are</b> Methods For Preparing Organic Light-Emitting Diodes Comprising These Emissive Materials, And The Use Of Such Diodes As White And Yellow Organic Light-Emitting Devices. published_or_final_versio...|$|E
40|$|Compositions {{and methods}} for {{detecting}} and controlling the conversion to mucoidy in Pseudomonas aeruginosa <b>are</b> <b>disclosed.</b> The present invention provides for detecting {{the switch from}} nonmucoid to mucoid state of P. aeruginosa by measuring mucE expression or MucE protein levels. The interaction between MucE and AlgW controls the switch to mucoidy in wild type P. aeruginosa. <b>Also</b> <b>disclosed</b> <b>is</b> an alginate biosynthesis heterologous expression system for use in screening candidate substances that inhibit conversion to mucoidy...|$|R
40|$|<b>Disclosed</b> <b>is</b> {{a method}} of {{estimating}} the state-of-charge of a rechargeable battery, {{taking into account the}} factors battery spread and ageing. The method comprises the steps of: determining the starting state-of-charge of the battery by measuring the voltage across the battery and converting this measured value into a state-of-charge value; charging the battery; integrating the charge current and determining the accumulated charge during charging of the battery and adding said value to the starting state-of-charge. <b>Also</b> <b>disclosed</b> <b>is</b> a method for determining the use time left of a rechargeable battery...|$|R
40|$|<b>Disclosed</b> <b>is</b> {{a system}} that uses {{existing}} power line infrastructure in a building as a distributed reception antenna capable of receiving signals from very low-power wireless sensors, thus allowing these sensors to be detected at ranges that are otherwise impractical with over-the-air reception. <b>Also</b> <b>disclosed</b> <b>is</b> a wireless sensor platform that is able to be sensed throughout a building with very low current draw. The <b>disclosed</b> technique may <b>also</b> <b>be</b> utilized to extend the range of mid-frequency consumer electronic devices by leveraging the power line as a reception antenna. Georgia Tech Research CorporationUniversity Of Washingto...|$|R
40|$|The present {{invention}} {{relates to}} the use of a cell, cell line or organism in which the activity of cyp 6 g 1 or derivatives thereof or fragments or either thereof is increased relative to wildtype activity of cyp 6 g 1 for the screening of putative pesticides. <b>Also</b> <b>disclosed</b> <b>are</b> cell, cell lines and organisms for use in the method...|$|E
40|$|Disclosed {{are high}} surface area {{nanoparticles}} {{that have a}} fibrous morphology. The nanoparticles have a plurality of fibers, wherein each fiber is in contact with one other fiber and each fiber has a length of between about 1 nm and about 5000 nm. <b>Also</b> <b>disclosed</b> <b>are</b> applications of the nanoparticles of the present invention, and methods of fabrication of the nanoparticles of the present invention...|$|E
40|$|A {{method for}} {{regulating}} Src and its downstream signaling pathway which includes binding between Src and Na+/K+-ATPase is disclosed. The Na+/K+-ATPase/Src complex is a functional receptor for cardiotonic steroids such as ouabain. <b>Also</b> <b>disclosed</b> <b>are</b> Src inhibitors or activators which include either Na+/K+-ATPase or Src {{that interfere with}} {{the interaction between the}} Na/K-ATPase and Src, act via a different mechanism from ATP analogs, and is pathway (Na+/K+-ATPase) specific...|$|E
40|$|A one-pot {{process for}} the {{preparation}} of functional alkoxyamines of the general formula (I), (See Formula I) <b>is</b> <b>disclosed.</b> The process entails (1) reacting an oxidizing agent with a sterically hindered secondary amine to produce an aqueous phase and a nitroxyl radical (2) removing the aqueous phase and adding to the nitroxyl radical one or more vinyl monomer(s) conforming to a formula and a system which produces free radicals. <b>Also</b> <b>disclosed</b> <b>is</b> a process of polymerizing monomers using the function al alkoxyamine...|$|R
40|$|Inhibition of {{dendritic}} cell function in solid organ grafts or allogeneic bone marrow transplants prior to or during engraftment by blocking SH 2 -containing inositol phosphatase (SHIP) expression or function is taught {{as a method}} of abrogating immune rejection and thereby increasing the efficacy of engraftment of an allogeneic bone marrow transplant or solid organ allograft or xenograft. <b>Also</b> <b>disclosed</b> <b>is</b> a transgenic mouse having the genotype SHIP−/− which exhibits enhanced survival following mismatched allogeneic marrow grafts...|$|R
40|$|The {{invention}} {{relates to}} a vacuum insulation panel (10) comprising a support element (11) in a gas-tight jacket (20) which {{has at least}} two components (21 22) especially film sections that are joined by means of spaced-apart sealing seams/flaps (25 a b). The sealing seams/flaps (25 a b) are positioned especially on a main surface (12) of the vacuum insulation panel (10). <b>Also</b> <b>disclosed</b> <b>is</b> a method for producing the vacuum insulation panel (10) according to the invention...|$|R
